Determination of Rank, Rankl and Opg Gene Polymorphisms in Triple-Negative Breast Cancer Patients and Investigation of its Effect on Bone Metastasis

Yildiz, Sukran; Al Saadoni, Hani; ALIUSTAOGLU, Mehmet; Ergen, Hayriye; Pence, Sadrettin

doi:10.33808/clinexphealthsci.533548

Determination of Rank, Rankl and Opg Gene Polymorphisms in Triple-Negative Breast Cancer Patients and Investigation of its Effect on Bone Metastasis

Atıf İçin Kopyala

Yildiz S., Al Saadoni H., ALIUSTAOGLU M., Ergen A., Pence S.

CLINICAL AND EXPERIMENTAL HEALTH SCIENCES, cilt.9, sa.4, ss.316-320, 2019 (ESCI)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 9 Sayı: 4
Basım Tarihi: 2019
Doi Numarası: 10.33808/clinexphealthsci.533548
Dergi Adı: CLINICAL AND EXPERIMENTAL HEALTH SCIENCES
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.316-320
İstanbul Üniversitesi Adresli: Evet

Özet

Objective: Triple negative breast cancer (TNBC) is a sub-type of breast cancer with the worst prognosis and highest risk of mortality. Bone metastasis is the most common metastasis type among women with breast cancer. RANK and OPG, are the members of the family of tumor necrosis factor (TNF), which is effective on osteoblastic and osteoclastic mechanisms. RANKL, interacts with RANK and leads to bone resorption, whereas it inhibits bone destruction when it interacts with OPG.